Lozivate-MF Ointment

Lozivate-MF Ointment

Product Description


Clobetasol 0.05%, Salicylic acid 3%, Lactic acid 3%, Urea 10%.



Lozivate MF ointment is a logical solution for dry scaly skin disorder; Lozivate MF is containing a synergy of four ingredients for better outcome, each of the agents is having an exclusive effect to treat the conditions of Dry scaly skin disorder..


Mechanism of Action:

In Lozivate MF ointment, Clobetasol propionate has anti-inflammatory, antipruritic, and vasoconstrictive properties. Acts by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. These proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2.

Salicylic acidoffers high desquamation activity, prevents pores from clogging up, allow new cell growth, & Improves symptoms and quality of life in all patients.

Ureahelps in hydration and reduces water loss from the skin.

Lactic acidprovides a moisturizing effect.



Psoriasis, viral warts, scaling, lichen simplex, & Ichthyosis, Prurigonodularis&Palmoplnatarkeratoderma

·         Improve dry scaly skin

·         Quick resolution of scales

·         Keratolytic effect

·         Improve moisture retention

·         Offers hydrolytic effect

·         Develops new smooth skin growth


Usage & Application:

Apply a thin layer of Lozivate-MF to the affected skin areas twice daily and rub gently and completely.


Storage Condition:

Store below 250 C (77CF) & to protect from light.


Pack: 30g Tube

Copyright © 2014 - All Rights Reserved Canixa Life Science